MDSpire - Summary
Feature

Next-Generation Spectacle Lens Aims to Strengthen Myopia Control in Children

New optical design targets stronger signal to slow axial elongation

  • March 25, 2026

  • 5 min

Share

The introduction of Essilor Stellest 2.0 represents a significant advancement in pediatric myopia management, aiming to slow axial elongation through innovative optical design. Utilizing H.A.L.T. MAX technology, the updated lenses increase both optical power and asphericity of microscopic lenslets to enhance myopia control. This follows evidence from clinical trials demonstrating a 1.88 times slower eye growth in children wearing the new lens compared to the original. As myopia prevalence rises among children globally, these non-invasive spectacles offer a promising intervention strategy.

Original Source(s)

Next-Generation Spectacle Lens Aims to Strengthen Myopia Control in Children

  • March 25, 2026

Related Content

Layer-Specific Corneal Changes in TED

TVST study identifies diffuse stromal thinning in patients with thyroid eye disease

  • March 25, 2026

  • 3 min
Could NPDR Be Treated Orally?

Phase 1b results for danegaptide indicate promising safety profile in patients with non-proliferative diabetic retinopathy and macular edema

  • March 24, 2026

  • 5 min
EYP-1901 in Wet AMD and DME: Insights from the Phase 2 DAVIO 2 and VERONA Trials

An overview of key visual and anatomic findings with EYP-1901 from the DAVIO 2 and VERONA clinical trials, presented at Macula Society 2026

  • March 24, 2026

  • 6 min